» Articles » PMID: 31552163

Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer

Overview
Journal Front Oncol
Specialty Oncology
Date 2019 Sep 26
PMID 31552163
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Alternative splicing (AS) has a critical role in tumor progression and prognosis. Our study aimed to investigate pancreatic cancer-specific AS events using RNA-seq data, gaining systematic insights into potential prognostic predictors. We downloaded 10,623 genes with 45,313 pancreatic cancer-specific AS events from the Cancer Genome Atlas (TCGA) and SpliceSeq database. Cox univariate analyses of overall survival suggested there was a remarkable association between 6,711 AS events and overall survival in pancreatic cancer patients ( < 0.05). The area under the curves (AUC) of the receiver operator characteristic curves (ROC) of risk score was 0.89 for final prognostic predictor. Results indicated that AS events of DAZAP1, RBM4, ESRP1, QKI, and SF1 were significantly associated with overall survival. The results of FunRich showed that transcription factors KLF7, GABPA, and SP1 were the most highly related to survival-associated AS genes. Furthermore, using DriverDBv2, we identified 13 driver genes associated with survival-associated AS events, including TP53 and CDC27. Thus, we concluded that the aberrant AS patterns in pancreatic cancer patients might serve as prognostic predictors.

Citing Articles

RNA-binding protein DAZAP1 accelerates the advancement of pancreatic cancer by inhibiting ferroptosis.

Wang X, Fan H, Ye X, Hu Y, Xiao Y, Zhang M Eur J Med Res. 2025; 30(1):3.

PMID: 39754243 PMC: 11699656. DOI: 10.1186/s40001-024-02261-0.


The Role of CENPK Splice Variant in Abiraterone Response in Metastatic Castration-Resistant Prostate Cancer.

Huang M, Qin S, Gao H, Kim W, Xie F, Yin P Cells. 2024; 13(19.

PMID: 39404386 PMC: 11475995. DOI: 10.3390/cells13191622.


Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target.

Sciarrillo R, Terrana F, Comandatore A, Supadmanaba I, Wang B, Hassouni B Int J Biol Sci. 2024; 20(8):3173-3184.

PMID: 38904016 PMC: 11186358. DOI: 10.7150/ijbs.92671.


The Many Roads from Alternative Splicing to Cancer: Molecular Mechanisms Involving Driver Genes.

Gimeno-Valiente F, Lopez-Rodas G, Castillo J, Franco L Cancers (Basel). 2024; 16(11).

PMID: 38893242 PMC: 11171328. DOI: 10.3390/cancers16112123.


RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing.

Maurin M, Ranjouri M, Megino-Luque C, Newberg J, Du D, Martin K Nat Commun. 2023; 14(1):8444.

PMID: 38114498 PMC: 10730836. DOI: 10.1038/s41467-023-44126-w.


References
1.
Sue N, Jack B, Eaton S, Pearson R, Funnell A, Turner J . Targeted disruption of the basic Krüppel-like factor gene (Klf3) reveals a role in adipogenesis. Mol Cell Biol. 2008; 28(12):3967-78. PMC: 2423134. DOI: 10.1128/MCB.01942-07. View

2.
Wang E, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C . Alternative isoform regulation in human tissue transcriptomes. Nature. 2008; 456(7221):470-6. PMC: 2593745. DOI: 10.1038/nature07509. View

3.
Dong J, Chen C . Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci. 2009; 66(16):2691-706. PMC: 11115749. DOI: 10.1007/s00018-009-0045-z. View

4.
Warzecha C, Shen S, Xing Y, Carstens R . The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events. RNA Biol. 2009; 6(5):546-62. PMC: 2823379. DOI: 10.4161/rna.6.5.9606. View

5.
Wei D, Wang L, Kanai M, Jia Z, Le X, Li Q . KLF4α up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology. 2010; 139(6):2135-45. PMC: 3245983. DOI: 10.1053/j.gastro.2010.08.022. View